| Record Information |
|---|
| Version | 5.0 |
|---|
| Status | Detected but not Quantified |
|---|
| Creation Date | 2021-09-10 23:10:27 UTC |
|---|
| Update Date | 2021-09-26 22:55:01 UTC |
|---|
| HMDB ID | HMDB0246137 |
|---|
| Secondary Accession Numbers | None |
|---|
| Metabolite Identification |
|---|
| Common Name | N-Methyl-4-oxo-1,4-dihydropyridine-3-carboxamide |
|---|
| Description | N-Methyl-4-oxo-1,4-dihydropyridine-3-carboxamide, also known as N(1)-methyl-4-pyridone-3-carboxamide, belongs to the class of organic compounds known as nicotinamides. These are heterocyclic aromatic compounds containing a pyridine ring substituted at position 3 by a carboxamide group. Based on a literature review very few articles have been published on N-Methyl-4-oxo-1,4-dihydropyridine-3-carboxamide. This compound has been identified in human blood as reported by (PMID: 31557052 ). N-methyl-4-oxo-1,4-dihydropyridine-3-carboxamide is not a naturally occurring metabolite and is only found in those individuals exposed to this compound or its derivatives. Technically N-Methyl-4-oxo-1,4-dihydropyridine-3-carboxamide is part of the human exposome. The exposome can be defined as the collection of all the exposures of an individual in a lifetime and how those exposures relate to health. An individual's exposure begins before birth and includes insults from environmental and occupational sources. |
|---|
| Structure | InChI=1S/C7H8N2O2/c1-8-7(11)5-4-9-3-2-6(5)10/h2-4H,1H3,(H,8,11)(H,9,10) |
|---|
| Synonyms | | Value | Source |
|---|
| N'-methyl-4-pyridone-3-carboxamide | HMDB | | N(1)-Methyl-4-pyridone-3-carboxamide | HMDB | | N(1)-Methyl-4-pyridone-5-carboxamide | HMDB |
|
|---|
| Chemical Formula | C7H8N2O2 |
|---|
| Average Molecular Weight | 152.153 |
|---|
| Monoisotopic Molecular Weight | 152.058577506 |
|---|
| IUPAC Name | N-methyl-4-oxo-1,4-dihydropyridine-3-carboxamide |
|---|
| Traditional Name | N-methyl-4-oxo-1H-pyridine-3-carboxamide |
|---|
| CAS Registry Number | Not Available |
|---|
| SMILES | CNC(=O)C1=CNC=CC1=O |
|---|
| InChI Identifier | InChI=1S/C7H8N2O2/c1-8-7(11)5-4-9-3-2-6(5)10/h2-4H,1H3,(H,8,11)(H,9,10) |
|---|
| InChI Key | BYSMVNPWERSAPZ-UHFFFAOYSA-N |
|---|
| Chemical Taxonomy |
|---|
| Description | Belongs to the class of organic compounds known as nicotinamides. These are heterocyclic aromatic compounds containing a pyridine ring substituted at position 3 by a carboxamide group. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Organoheterocyclic compounds |
|---|
| Class | Pyridines and derivatives |
|---|
| Sub Class | Pyridinecarboxylic acids and derivatives |
|---|
| Direct Parent | Nicotinamides |
|---|
| Alternative Parents | |
|---|
| Substituents | - Nicotinamide
- Dihydropyridine
- Hydropyridine
- Heteroaromatic compound
- Vinylogous amide
- Cyclic ketone
- Secondary carboxylic acid amide
- Carboxamide group
- Azacycle
- Carboxylic acid derivative
- Organic nitrogen compound
- Organic oxygen compound
- Organopnictogen compound
- Organic oxide
- Hydrocarbon derivative
- Organooxygen compound
- Organonitrogen compound
- Aromatic heteromonocyclic compound
|
|---|
| Molecular Framework | Aromatic heteromonocyclic compounds |
|---|
| External Descriptors | Not Available |
|---|
| Ontology |
|---|
| Physiological effect | Not Available |
|---|
| Disposition | |
|---|
| Process | Not Available |
|---|
| Role | Not Available |
|---|
| Physical Properties |
|---|
| State | Not Available |
|---|
| Experimental Molecular Properties | | Property | Value | Reference |
|---|
| Melting Point | Not Available | Not Available | | Boiling Point | Not Available | Not Available | | Water Solubility | Not Available | Not Available | | LogP | Not Available | Not Available |
|
|---|
| Experimental Chromatographic Properties | Not Available |
|---|
| Predicted Molecular Properties | |
|---|
| Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Retention Times Underivatized| Chromatographic Method | Retention Time | Reference |
|---|
| Predicted by Siyang on May 30, 2022 | 8.5671 minutes | 33406817 | | Predicted by Siyang using ReTip algorithm on June 8, 2022 | 1.83 minutes | 32390414 | | Fem_Long = Waters ACQUITY UPLC HSS T3 C18 with Water:MeOH and 0.1% Formic Acid | 977.3 seconds | 40023050 | | Fem_Lipids = Ascentis Express C18 with (60:40 water:ACN):(90:10 IPA:ACN) and 10mM NH4COOH + 0.1% Formic Acid | 287.0 seconds | 40023050 | | Life_Old = Waters ACQUITY UPLC BEH C18 with Water:(20:80 acetone:ACN) and 0.1% Formic Acid | 80.9 seconds | 40023050 | | Life_New = RP Waters ACQUITY UPLC HSS T3 C18 with Water:(30:70 MeOH:ACN) and 0.1% Formic Acid | 169.9 seconds | 40023050 | | RIKEN = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 63.4 seconds | 40023050 | | Eawag_XBridgeC18 = XBridge C18 3.5u 2.1x50 mm with Water:MeOH and 0.1% Formic Acid | 245.7 seconds | 40023050 | | BfG_NTS_RP1 =Agilent Zorbax Eclipse Plus C18 (2.1 mm x 150 mm, 3.5 um) with Water:ACN and 0.1% Formic Acid | 278.4 seconds | 40023050 | | HILIC_BDD_2 = Merck SeQuant ZIC-HILIC with ACN(0.1% formic acid):water(16 mM ammonium formate) | 307.6 seconds | 40023050 | | UniToyama_Atlantis = RP Waters Atlantis T3 (2.1 x 150 mm, 5 um) with ACN:Water and 0.1% Formic Acid | 593.7 seconds | 40023050 | | BDD_C18 = Hypersil Gold 1.9µm C18 with Water:ACN and 0.1% Formic Acid | 79.0 seconds | 40023050 | | UFZ_Phenomenex = Kinetex Core-Shell C18 2.6 um, 3.0 x 100 mm, Phenomenex with Water:MeOH and 0.1% Formic Acid | 828.6 seconds | 40023050 | | SNU_RIKEN_POS = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 186.9 seconds | 40023050 | | RPMMFDA = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 192.0 seconds | 40023050 | | MTBLS87 = Merck SeQuant ZIC-pHILIC column with ACN:Water and :ammonium carbonate | 528.2 seconds | 40023050 | | KI_GIAR_zic_HILIC_pH2_7 = Merck SeQuant ZIC-HILIC with ACN:Water and 0.1% FA | 225.2 seconds | 40023050 | | Meister zic-pHILIC pH9.3 = Merck SeQuant ZIC-pHILIC column with ACN:Water 5mM NH4Ac pH9.3 and 5mM ammonium acetate in water | 175.6 seconds | 40023050 |
Predicted Kovats Retention IndicesUnderivatizedDerivatized| Derivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
|---|
| N-Methyl-4-oxo-1,4-dihydropyridine-3-carboxamide,1TMS,isomer #1 | CN(C(=O)C1=C[NH]C=CC1=O)[Si](C)(C)C | 1603.2 | Semi standard non polar | 33892256 | | N-Methyl-4-oxo-1,4-dihydropyridine-3-carboxamide,1TMS,isomer #1 | CN(C(=O)C1=C[NH]C=CC1=O)[Si](C)(C)C | 1683.3 | Standard non polar | 33892256 | | N-Methyl-4-oxo-1,4-dihydropyridine-3-carboxamide,1TMS,isomer #1 | CN(C(=O)C1=C[NH]C=CC1=O)[Si](C)(C)C | 1987.4 | Standard polar | 33892256 | | N-Methyl-4-oxo-1,4-dihydropyridine-3-carboxamide,1TMS,isomer #2 | CNC(=O)C1=CN([Si](C)(C)C)C=CC1=O | 1743.4 | Semi standard non polar | 33892256 | | N-Methyl-4-oxo-1,4-dihydropyridine-3-carboxamide,1TMS,isomer #2 | CNC(=O)C1=CN([Si](C)(C)C)C=CC1=O | 1785.8 | Standard non polar | 33892256 | | N-Methyl-4-oxo-1,4-dihydropyridine-3-carboxamide,1TMS,isomer #2 | CNC(=O)C1=CN([Si](C)(C)C)C=CC1=O | 2148.6 | Standard polar | 33892256 | | N-Methyl-4-oxo-1,4-dihydropyridine-3-carboxamide,2TMS,isomer #1 | CN(C(=O)C1=CN([Si](C)(C)C)C=CC1=O)[Si](C)(C)C | 1788.2 | Semi standard non polar | 33892256 | | N-Methyl-4-oxo-1,4-dihydropyridine-3-carboxamide,2TMS,isomer #1 | CN(C(=O)C1=CN([Si](C)(C)C)C=CC1=O)[Si](C)(C)C | 1888.1 | Standard non polar | 33892256 | | N-Methyl-4-oxo-1,4-dihydropyridine-3-carboxamide,2TMS,isomer #1 | CN(C(=O)C1=CN([Si](C)(C)C)C=CC1=O)[Si](C)(C)C | 1971.8 | Standard polar | 33892256 | | N-Methyl-4-oxo-1,4-dihydropyridine-3-carboxamide,1TBDMS,isomer #1 | CN(C(=O)C1=C[NH]C=CC1=O)[Si](C)(C)C(C)(C)C | 1857.0 | Semi standard non polar | 33892256 | | N-Methyl-4-oxo-1,4-dihydropyridine-3-carboxamide,1TBDMS,isomer #1 | CN(C(=O)C1=C[NH]C=CC1=O)[Si](C)(C)C(C)(C)C | 1876.6 | Standard non polar | 33892256 | | N-Methyl-4-oxo-1,4-dihydropyridine-3-carboxamide,1TBDMS,isomer #1 | CN(C(=O)C1=C[NH]C=CC1=O)[Si](C)(C)C(C)(C)C | 2145.8 | Standard polar | 33892256 | | N-Methyl-4-oxo-1,4-dihydropyridine-3-carboxamide,1TBDMS,isomer #2 | CNC(=O)C1=CN([Si](C)(C)C(C)(C)C)C=CC1=O | 2012.4 | Semi standard non polar | 33892256 | | N-Methyl-4-oxo-1,4-dihydropyridine-3-carboxamide,1TBDMS,isomer #2 | CNC(=O)C1=CN([Si](C)(C)C(C)(C)C)C=CC1=O | 1992.4 | Standard non polar | 33892256 | | N-Methyl-4-oxo-1,4-dihydropyridine-3-carboxamide,1TBDMS,isomer #2 | CNC(=O)C1=CN([Si](C)(C)C(C)(C)C)C=CC1=O | 2265.5 | Standard polar | 33892256 | | N-Methyl-4-oxo-1,4-dihydropyridine-3-carboxamide,2TBDMS,isomer #1 | CN(C(=O)C1=CN([Si](C)(C)C(C)(C)C)C=CC1=O)[Si](C)(C)C(C)(C)C | 2264.1 | Semi standard non polar | 33892256 | | N-Methyl-4-oxo-1,4-dihydropyridine-3-carboxamide,2TBDMS,isomer #1 | CN(C(=O)C1=CN([Si](C)(C)C(C)(C)C)C=CC1=O)[Si](C)(C)C(C)(C)C | 2282.3 | Standard non polar | 33892256 | | N-Methyl-4-oxo-1,4-dihydropyridine-3-carboxamide,2TBDMS,isomer #1 | CN(C(=O)C1=CN([Si](C)(C)C(C)(C)C)C=CC1=O)[Si](C)(C)C(C)(C)C | 2220.5 | Standard polar | 33892256 |
|
|---|
| GC-MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Predicted GC-MS | Predicted GC-MS Spectrum - N-Methyl-4-oxo-1,4-dihydropyridine-3-carboxamide GC-MS (Non-derivatized) - 70eV, Positive | splash10-00di-2900000000-97491fc004413d013e6e | 2021-09-23 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - N-Methyl-4-oxo-1,4-dihydropyridine-3-carboxamide GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum |
MS/MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - N-Methyl-4-oxo-1,4-dihydropyridine-3-carboxamide 10V, Positive-QTOF | splash10-00di-1900000000-dd7aa8195f2b0e36b8aa | 2021-10-12 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - N-Methyl-4-oxo-1,4-dihydropyridine-3-carboxamide 20V, Positive-QTOF | splash10-00di-9800000000-3fd2e8e6c99e75302c99 | 2021-10-12 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - N-Methyl-4-oxo-1,4-dihydropyridine-3-carboxamide 40V, Positive-QTOF | splash10-0g4l-9200000000-9865259ae3c6cfa6d704 | 2021-10-12 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - N-Methyl-4-oxo-1,4-dihydropyridine-3-carboxamide 10V, Negative-QTOF | splash10-0udi-2900000000-75074348c3325bb1c921 | 2021-10-12 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - N-Methyl-4-oxo-1,4-dihydropyridine-3-carboxamide 20V, Negative-QTOF | splash10-0006-9000000000-d5cc5210f3c0f17decaa | 2021-10-12 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - N-Methyl-4-oxo-1,4-dihydropyridine-3-carboxamide 40V, Negative-QTOF | splash10-00kf-9000000000-726d18e48f12edbbcc63 | 2021-10-12 | Wishart Lab | View Spectrum |
NMR Spectra| Spectrum Type | Description | Deposition Date | Source | View |
|---|
| Predicted 1D NMR | 1H NMR Spectrum (1D, 100 MHz, D2O, predicted) | 2021-10-13 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 100 MHz, D2O, predicted) | 2021-10-13 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 1000 MHz, D2O, predicted) | 2021-10-13 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 1000 MHz, D2O, predicted) | 2021-10-13 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 200 MHz, D2O, predicted) | 2021-10-13 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 200 MHz, D2O, predicted) | 2021-10-13 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 300 MHz, D2O, predicted) | 2021-10-13 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 300 MHz, D2O, predicted) | 2021-10-13 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 400 MHz, D2O, predicted) | 2021-10-13 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 400 MHz, D2O, predicted) | 2021-10-13 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 500 MHz, D2O, predicted) | 2021-10-13 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 500 MHz, D2O, predicted) | 2021-10-13 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 600 MHz, D2O, predicted) | 2021-10-13 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 600 MHz, D2O, predicted) | 2021-10-13 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 700 MHz, D2O, predicted) | 2021-10-13 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 700 MHz, D2O, predicted) | 2021-10-13 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 800 MHz, D2O, predicted) | 2021-10-13 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 800 MHz, D2O, predicted) | 2021-10-13 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 900 MHz, D2O, predicted) | 2021-10-13 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 900 MHz, D2O, predicted) | 2021-10-13 | Wishart Lab | View Spectrum |
|
|---|